Related Experiment Videos
[Familial Mediterranean fever. No longer an elimination diagnosis]
U B Dragsted1, J Eugen-Olsen, L R Mathiesen
1H:S Hvidovre Hospital, infektionsmedicinsk afdeling og forskningsenheden. u.dragsted@post.uni2.dk
Abstract:
Familial Mediterranean Fever (FMF) is a recessive trait mainly affecting Jews, Turks and Arabs. FMF is characterized by recurrent episodes of painful serositis and fever leaving no sequelae. Involvement of the peritoneum is the most common clinical form. In 1997 the gene that causes FMF (MEFV-gene) was cloned, thus given clinicians an opportunity to diagnose the disease. We have established the method in our laboratory. We describe the first patient diagnosed with FMF in our department by this method.
Insights
Familial Mediterranean Fever (FMF), a genetic disorder, is now diagnosable via MEFV gene testing. This advancement allows for earlier detection and management of FMF in affected populations.
Area of Science:
- Genetics
- Immunology
- Internal Medicine
Background:
- Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disorder.
- It is characterized by recurrent episodes of fever and serositis, primarily affecting individuals of Mediterranean and Middle Eastern descent.
- The peritoneum is the most commonly involved site.
Observation:
- The MEFV gene, responsible for FMF, was identified in 1997.
- Genetic testing for the MEFV gene provides a diagnostic opportunity for clinicians.
- The laboratory has successfully established this diagnostic method.
Findings:
- The study reports the first patient diagnosed with FMF in their department using the established MEFV gene testing method.
- This highlights the successful implementation of genetic diagnostics for FMF.
Implications:
- Early and accurate diagnosis of FMF through genetic testing can lead to timely intervention.
- This diagnostic capability can improve patient outcomes and disease management.
- The established method facilitates genetic diagnosis of FMF in clinical practice.